Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael Berszin"'
Autor:
Louisa Röhl, Jana Wellhausen, Michael Berszin, Irene Krücken, Veit Zebralla, Markus Pirlich, Susanne Wiegand, Andreas Dietz, Theresa Wald, Gunnar Wichmann
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundImmune-checkpoint blockade (ICB) of programmed-death-1 (PD-1) with pembrolizumab or nivolumab is approved for treating recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). NadiHN and ADRISK are phase IIB trials investig
Externí odkaz:
https://doaj.org/article/2844b68fdef74e30ab5deaea9b3f11fe
Autor:
Michael Berszin, Ioannis Michaelides, Julia Siemert, Louisa Röhl, Jana Wellhausen, Theresa Wald, Christopher Bohr, Julian Künzel, Tanja Gradistanac, Andreas Dietz, Veit Zebralla, Markus Pirlich, Susanne Wiegand, Gunnar Wichmann
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPembrolizumab and cetuximab are antibodies under investigation in head and neck squamous cell carcinoma (HNSCC) either as single agents or combined with cisplatin and other chemotherapeutic drugs, e.g., 5-fluorouracil and/or docetaxel. Howe
Externí odkaz:
https://doaj.org/article/fba7c6a52eb84eb0b50232b2a2c26e9c
Autor:
Ioannis Michaelides, Sandra Fest, Michael Berszin, Susanne Wiegand, Christopher Bohr, Julian Künzel, Andreas Dietz, Markus Pirlich, Gunnar Wichmann
Publikováno v:
Laryngo-Rhino-Otologie. 101:736-740
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b64c6bbc1a304b97f7138b1af41150
https://doi.org/10.1055/a-1830-8298
https://doi.org/10.1055/a-1830-8298
Autor:
Ioannis, Michaelides, Sandra, Fest, Michael, Berszin, Susanne, Wiegand, Christopher, Bohr, Julian, Künzel, Andreas, Dietz, Markus, Pirlich, Gunnar, Wichmann
Publikováno v:
Laryngo- rhino- otologie. 101(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9211e556e3134e82a3aee1da42fa8d8
https://pubmed.ncbi.nlm.nih.gov/35576974
https://pubmed.ncbi.nlm.nih.gov/35576974